Top insider buys: Jun 30 – Jul 6, 2025

The largest open-market purchases company insiders reported on SEC Form 4 between Jun 30 – Jul 6, 2025.

Week 27, 2025

#	Company	Who bought	Shares	Value	Source
1	KYMR Kymera Therapeutics, Inc.	2 officers/directors Cluster buy BVF PARTNERS L P/IL, BAKER BROS. ADVISORS LP	972,667	$42.8M	SEC filings
2	ACTU ACTUATE THERAPEUTICS, INC.	3 officers/directors Cluster buy Bios Equity COF, LP, Kreis Leslie W., Fletcher Aaron G.L.	214,284	$1.5M	SEC filings
3	FGBI First Guaranty Bancshares, Inc.	4 officers/directors Cluster buy Hood William K, Smith Edgar R. III, REYNOLDS MARSHALL T, McAnally Bruce	123,460	$1.0M	SEC filings
4	BCDA BioCardia, Inc.	2 officers/directors Cluster buy STERTZER SIMON H, Blank Andrew Scott	144,578	$300K	SEC filings
5	CDTX Cidara Therapeutics, Inc.	Director RA CAPITAL MANAGEMENT, L.P.	2,272,727	$100.0M	SEC filings
6	ASAN Asana, Inc.	President, CEO, & Chair Moskovitz Dustin A.	450,000	$6.1M	SEC filings
7	PLUR Pluri Inc.	Director Manieu Alexandre Weinstein	976,139	$4.5M	SEC filings
8	PRM Perimeter Solutions, Inc.	10% Owner WindAcre Partnership Master Fund, LP	254,600	$3.6M	SEC filings
9	WELL WELLTOWER INC.	Director Gundlach Andrew	20,000	$3.0M	SEC filings
10	FUND SPROTT FOCUS TRUST INC.	Director GEORGE W WHITNEY	196,329	$1.5M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.